Yasui H - Search Results

1

Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.

Watanabe J, Muro K, Shitara K, Yamazaki K, Shiozawa M, Ohori H, Takashima A, Yokota M, Makiyama A, Akazawa N, Ojima H, Yuasa Y, Miwa K, Yasui H, Oki E, Sato T, Naitoh T, Komatsu Y, Kato T, Hihara M, Soeda J, Misumi T, Yamamoto K, Akagi K, Ochiai A, Uetake H, Tsuchihara K, Yoshino T. Watanabe J, et al. Among authors: yasui h. JAMA. 2023 Apr 18;329(15):1271-1282. doi: 10.1001/jama.2023.4428. JAMA. 2023. PMID: 37071094 Free PMC article. Clinical Trial.

2

Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel.

Matsuoka M, Boku N, Yoshino T, Hironaka S, Onozawa Y, Fukutomi A, Zenda S, Yamazaki K, Yasui H, Hasuike N, Inui T, Yamaguchi Y, Ono H, Kamata M. Matsuoka M, et al. Among authors: yasui h. Int J Clin Oncol. 2005 Dec;10(6):429-32. doi: 10.1007/s10147-005-0502-0. Int J Clin Oncol. 2005. PMID: 16369748

3

Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer.

Goto A, Yamada Y, Yasui H, Kato K, Hamaguchi T, Muro K, Shimada Y, Shirao K. Goto A, et al. Among authors: yasui h. Ann Oncol. 2006 Jun;17(6):968-73. doi: 10.1093/annonc/mdl066. Epub 2006 Apr 7. Ann Oncol. 2006. PMID: 16603600 Free article. Clinical Trial.

4

The role of the outpatient clinic in chemotherapy for patients with unresectable or recurrent gastric cancer.

Yamazaki K, Boku N, Shibamoto K, Yasui H, Fukutomi A, Yoshino T, Hironaka S, Onozawa Y, Otake Y, Hasuike N, Matsubayashi H, Inui T, Yamaguchi Y, Ono H. Yamazaki K, et al. Among authors: yasui h. Jpn J Clin Oncol. 2007 Feb;37(2):96-101. doi: 10.1093/jjco/hyl145. Epub 2007 Feb 1. Jpn J Clin Oncol. 2007. PMID: 17272316

5

Chemosensitivity of patients with recurrent esophageal cancer receiving perioperative chemotherapy.

Takashima A, Shirao K, Hirashima Y, Takahari D, Okita N, Akatsuka S, Nakajima TE, Matsubara J, Yasui H, Asakawa T, Kato K, Hamguchi T, Muro K, Yamada Y, Shimada Y. Takashima A, et al. Among authors: yasui h. Dis Esophagus. 2008;21(7):607-11. doi: 10.1111/j.1442-2050.2008.00821.x. Epub 2008 Apr 22. Dis Esophagus. 2008. PMID: 18430178

6

A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum.

Yamazaki K, Hironaka S, Boku N, Yasui H, Fukutomi A, Yoshino T, Onozawa Y, Hasuike N, Inui T, Yamaguchi Y, Ono H. Yamazaki K, et al. Among authors: yasui h. Int J Clin Oncol. 2008 Apr;13(2):150-5. doi: 10.1007/s10147-007-0738-y. Epub 2008 May 8. Int J Clin Oncol. 2008. PMID: 18463960

7

Impact of baseline sum of longest diameter in target lesions by RECIST on survival of patients with metastatic colorectal cancer.

Machida N, Yoshino T, Boku N, Hironaka S, Onozawa Y, Fukutomi A, Yamazaki K, Yasui H, Taku K, Asaka M. Machida N, et al. Among authors: yasui h. Jpn J Clin Oncol. 2008 Oct;38(10):689-94. doi: 10.1093/jjco/hyn086. Jpn J Clin Oncol. 2008. PMID: 18845522

8

Irinotecan plus cisplatin therapy and S-1 plus cisplatin therapy for advanced or recurrent gastric cancer in a single institution.

Nakashima K, Hironaka S, Boku N, Onozawa Y, Fukutomi A, Yamazaki K, Yasui H, Taku K, Kojima T, Machida N. Nakashima K, et al. Among authors: yasui h. Jpn J Clin Oncol. 2008 Dec;38(12):810-5. doi: 10.1093/jjco/hyn109. Epub 2008 Nov 6. Jpn J Clin Oncol. 2008. PMID: 18988666

9

Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer.

Taira K, Boku N, Fukutomi A, Onozawa Y, Hironaka S, Yoshino T, Yasui H, Yamazaki K, Taku K, Hashimoto T, Nishimura T. Taira K, et al. Among authors: yasui h. J Gastroenterol. 2008;43(11):875-80. doi: 10.1007/s00535-008-2236-z. Epub 2008 Nov 18. J Gastroenterol. 2008. PMID: 19012041

10

Retrospective analysis of S-1 monotherapy in patients with metastatic colorectal cancer after failure to fluoropyrimidine and irinotecan or to fluoropyrimidine, irinotecan and oxaliplatin.

Yasui H, Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamazaki K, Taku K, Kojima T, Machida N. Yasui H, et al. Jpn J Clin Oncol. 2009 May;39(5):315-20. doi: 10.1093/jjco/hyp014. Jpn J Clin Oncol. 2009. PMID: 19403734

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,284 results

Search Page